Geneva, Sept. 21 -- International Clinical Trials Registry received information related to the study (ChiCTR2600132080) titled 'Study on the Safety and Efficacy of Hyperbaric Oxygen Therapy for Severe Fever with Thrombocytopenia Syndrome' on Sept. 9.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Beijing Ditan Hospital, Capital Medical University
Condition:
severe fever with thrombocytopenia syndrome
Intervention:
Conventional treatment combined with HBO therapy group:1. Basic treatment (administered to both groups of patients)
2. Hyperbaric oxygen therapy as an adjunct treatment.
Recruitment Status: Not Recruiting
Phase: N/A
Date of First Enrollment: 2026-09-09
Target Sample Size: Conventional tre...